Inflammation-related effects of adjuvant influenza A vaccination on platelet activation and cardiac autonomic function

Journal of Internal Medicine

Volumn 269, Issue 1, 2011, Pages 118-125

  Lanza, Gaetano A ^a   Barone, Lucy ^a   Scalone, Giancarla ^a   Pitocco, Dario ^b   Sgueglia, Gregory A ^a   Mollo, Roberto ^a   Nerla, Roberto ^a   Zaccardi, Francesco ^b   Ghirlanda, Giovanni ^b   Crea, Filippo ^a  

^a Divisione di Cardiologia   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Autonomic nervous function; Heart rate variability; Inflammation; Influenza A vaccine; Platelet reactivity

Indexed keywords

C REACTIVE PROTEIN; INFLUENZA VACCINE; INTERLEUKIN 6; THROMBOCYTE RECEPTOR;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; HEART FUNCTION; HEART RATE VARIABILITY; HOLTER MONITORING; HUMAN; HUMAN CELL; INFLAMMATION; INFLUENZA VACCINATION; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; RR INTERVAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

AGED; AUTONOMIC NERVOUS SYSTEM; C-REACTIVE PROTEIN; CELL AGGREGATION; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERLEUKIN-6; MALE; MIDDLE AGED; MONOCYTES; PLATELET ACTIVATION; PLATELET AGGREGATION;

EID: 78650215599     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02285.x     Document Type: Article

References (39)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
2. Biasucci LM, Vitelli A, Liuzzo G et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996; 94: 874-7.
3. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
4. Liuzzo G, Biasucci LM, Gallimore JR et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
5. Ridker PM, Henneckens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
6. Cesari M, Penninx BW, Newman AB et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108: 2317-22.
7. Trip MD, Cats VM, van Capelle FJ, Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N Engl J Med 1990; 322: 1549-54.
8. Lippi G, Montagnana M, Salvagno GL et al. Risk stratification of patients with acute myocardial infarction by quantification of circulating monocyte-platelet aggregates. Int J Cardiol 2007; 115: 101-2.
9. Bigger T, Fleiss JL, Steinman RC, Rolnitzky LM, Schneider WJ, Stein PK. RR variability in healthy, middle-aged persons compared with patients with chronic coronary heart disease or recent acute myocardial infarction. Circulation 1995; 91: 1936-43.
10. Tsuji H, Larson MG, Venditti Jr FJ et al. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation 1996; 94: 2850-5.
11. Lanza GA, Guido V, Galeazzi M et al. Prognostic role of heart rate variability in patients with a recent acute myocardial infarction. Am J Cardiol 1998; 82: 1323-8.
12. Lanza GA, Cianflone D, Rebuzzi AG et al., Stratificazione Prognostica dell'Angina Instabile Study Investigators Prognostic value of ventricular arrhythmias and heart rate variability in patients with unstable angina. Heart 2006; 92: 1055-63.
13. Weyrich AS, Lindemann S, Zimmerman A. The evolving role of platelets in inflammation. J Thromb Haemost 2003; 1: 1897-905.
14. Wagner DD, Burger PC. Platelets in inflammation and thrombosis. Arterioscler Thromb Vasc Biol 2003; 23: 2131-7.
15. Modica A, Karlsson F, Mooe T. Platelet aggregation and aspirin non responsiveness increase when an acute coronary syndrome is complicated by an infection. J Thromb Haemost 2007; 5: 507-11.
16. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES. The sympathetic nerve: an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000; 52: 595-638.
17. Pavlov VA, Wang H, Czura CJ, Friedman SG, Tracey KJ. The cholinergic anti-inflammatory pathway: a missing link in neuroimmunomodulation. Mol Med 2003; 9: 125-34.
18. Pavlov VA, Tracey KJ. Neural regulators of innate immune responses and inflammation. Cell Mol Life Sci 2004; 61: 2322-31.
19. Sajadieh A, Nielsen OW, Rasmussen V, Hein HO, Abedini S, Hansen JF. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur Heart J 2004; 25: 363-70.
20. Janszky I, Ericson M, Lekander M et al. Inflammatory markers and heart rate variability in women with coronary heart disease. J Intern Med 2004; 256: 421-8.
21. Lanza GA, Sgueglia GA, Cianflone D et al. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina pectoris. Am J Cardiol 2006; 97: 1702-6.
22. Malave HA, Taylor AA, Nattama J, Deswal A, Mann DL. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 2003; 123: 716-24.
23. Feery BJ, Hartman LJ, Hampson AW, Proietto J. Influenza immunization in adults with diabetes mellitus. Diabetes Care 1983; 6: 475-8.
24. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104: 1533-7.
25. Furman MI, Barnard MR, Krueger LA et al. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38: 1002-6.
26. Meier CR, Jick SS, Derby LE, Vasilakis C, Jick H. Acute respiratory-tract infection and risk of first-time acute myocardial infarction. Lancet 1998; 351: 1467-71.
27. Mattila KJ. Viral and bacterial infections in acute myocardial infarction. J Intern Med 1989; 225: 293-6.
28. Bainton D, Jones GR, Hole D. Influenza and ischaemic heart disease a possible trigger for acute myocardial infarction? Int J Epidemiol 1978; 7: 231-9.
29. Hingorani AD, Cross J, Kharbanda RK et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation 2000; 102: 994-9.
30. Aikawa M, Libby P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc Pathol 2004; 13: 125-38.
31. Gurfinkel EP, Leon de la Fuente R, Mendiz O, Mautner B. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 2004; 25: 25-31.
32. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000; 102: 3039-45.
33. Jackson LA, Yu O, Heckbert SR et al., the Vaccine Safety Datalink Study Group Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002; 156: 634-40.
34. Rathmann W, Ziegler D, Jahnke M, Haastert B, Gries FA. Mortality in diabetic patients with cardiovascular autonomic neuropathy. Diabet Med 1993; 10: 820-4.
35. Borovikova LV, Ivanova S, Zhang M et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62.
36. Borovikova LV, Ivanova S, Nardi D et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 2000; 85: 141-7.
37. Wang H, Yu M, Ochani M et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8.
38. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-9.
39. Lanza GA, Pitocco D, Navarese EP et al. Association between cardiac autonomic dysfunction and inflammation in type 1 diabetic patients: effect of beta-blockade. Eur Heart J 2007; 28: 814-20.